Medical Cannabis Findings From Clinical Research

Researchers from the University of Sydney are launching an Australia-wide online survey of people who have used cannabis for MEDICAL (therapeutic) purposes within the last 12 months. Australian residents only.

Recruitment: Expected April 2020

Study: A Double-blind, Placebo-controlled Study Investigating the Safety, Tolerability, Efficacy and Pharmacokinetics of EP1, an Enriched Cannabidiol Oil, in Children and Adolescents with Medication Resistant, Refractory Epilepsy

Research Collaborators: Melbourne Brain Centre (contact Mr Paul Lightfoot), Cann Pharmaceutical Aust Ltd Ltd

About the Study: The study will aim to determine if EP1 is an effective treatment for refractory epilepsy in children, adolescents and young adults by comparing different doses of EP1 against a placebo by measuring seizure frequency and character.

Publication: Pending

Recruitment: Closed

Study: Exploring the effects of THC and CBD on simulated driving.

Research Collaborators: The Lambert Initiative at the University of Sydney, Royal Prince Alfred Hospital and Tilray.

Chief Investigators: Professor Iain McGregor (Lambert Initiative, University of Sydney)

Completed: 2018

About the Study: This study explores the idea that CBD content in cannabis plant material will modify the effects of THC on driving, and investigates the link between concentrations of cannabinoids in blood and saliva, and driving ability. Drug testing of saliva and blood followed current Australian police procedures. A secondary aim of the study was to examine the relationship between positive results on these tests and actual driving impairment, currently a very controversial topic in the community and in legal circles.

Publication: Pending